Your session is about to expire
← Back to Search
CBT + Exercise for Diabetes Prevention in Adolescents (CBTeX Trial)
N/A
Recruiting
Research Sponsored by Colorado State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Age 12-17 years
Female
Must not have
T2D/ Type 1 Diabetes (T1D) or any major medical condition (e.g. cardiovascular, renal) that would prohibit the ability to participate in exercise training
Regular medication use affecting mood, insulin, or weight, including stimulants, anti-depressants, anti-psychotics, insulin sensitizers, weight loss medications & chronic steroids
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1-year
Awards & highlights
No Placebo-Only Group
Summary
This trial is researching how to prevent type 2 diabetes in teenage girls using cognitive-behavioral therapy, exercise training, or a combination of the two.
Who is the study for?
This trial is for teenage girls aged 12-17 who are at risk for type 2 diabetes due to family history, show signs of depression, and have a higher body weight for their age. They shouldn't have diabetes or major medical conditions, mental disorders like schizophrenia or eating disorders, be on mood-altering medications, or be pregnant.
What is being tested?
The study tests if cognitive-behavioral therapy (CBT), exercise training, or both can reduce stress and improve mood and physical fitness in teens at risk for diabetes. It aims to see if these interventions also lower insulin resistance which is linked to developing diabetes.
What are the potential side effects?
Potential side effects from the interventions might include discomfort during exercise and emotional distress during CBT sessions. However, these activities are generally considered safe with proper supervision.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am between 12 and 17 years old.
Select...
I am female.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I do not have major health issues that prevent me from exercising.
Select...
I use medications that affect my mood, insulin levels, or weight.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1-year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1-year
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Insulin Resistance
Secondary study objectives
Adiposity
BMI
Cardiorespiratory fitness
+10 moreOther study objectives
Automatic thoughts
Body image
Mindfulness
+3 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
4Treatment groups
Experimental Treatment
Active Control
Group I: Cognitive-Behavioral Therapy followed by Exercise TrainingExperimental Treatment1 Intervention
6-week cognitive-behavioral therapy intervention of 6 weekly 1-hour group sessions followed by a 6-week exercise training intervention of 6 weekly 1-hour group sessions
Group II: Cognitive-Behavioral Therapy OnlyActive Control1 Intervention
6-week cognitive-behavioral therapy intervention of 6 weekly 1-hour group sessions followed by an additional 6-week cognitive-behavioral therapy intervention of 6 weekly 1-hour group sessions
Group III: Exercise Training followed by Cognitive-Behavioral TherapyActive Control1 Intervention
6-week exercise training intervention of 6 weekly 1-hour group sessions followed by a 6-week cognitive-behavioral therapy intervention of 6 weekly 1-hour group sessions
Group IV: Exercise Training OnlyActive Control1 Intervention
6-week exercise training intervention of 6 weekly 1-hour group sessions followed by an additional 6-week exercise training intervention of 6 weekly 1-hour group sessions
Find a Location
Who is running the clinical trial?
Colorado State UniversityLead Sponsor
132 Previous Clinical Trials
38,127 Total Patients Enrolled
6 Trials studying Insulin Resistance
459 Patients Enrolled for Insulin Resistance
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH
2,449 Previous Clinical Trials
4,332,167 Total Patients Enrolled
93 Trials studying Insulin Resistance
13,172 Patients Enrolled for Insulin Resistance
University of Colorado, DenverOTHER
1,806 Previous Clinical Trials
2,822,106 Total Patients Enrolled
28 Trials studying Insulin Resistance
1,652 Patients Enrolled for Insulin Resistance
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I do not have major health issues that prevent me from exercising.I am between 12 and 17 years old.I am female.I have a parent, sibling, or grandparent with Type 2 Diabetes.You have been diagnosed with certain mental health conditions including conduct disorder, substance abuse/dependence, obsessive compulsive disorder, panic attacks, post-traumatic stress disorder, anorexia/bulimia, and schizophrenia.I am undergoing psychotherapy, a structured weight loss program, or had bariatric surgery.I use medications that affect my mood, insulin levels, or weight.If your depression score is 21 or higher on the CES-D scale, you may not be able to participate.Your weight is higher than what is considered healthy for your age and sex.
Research Study Groups:
This trial has the following groups:- Group 1: Cognitive-Behavioral Therapy Only
- Group 2: Cognitive-Behavioral Therapy followed by Exercise Training
- Group 3: Exercise Training followed by Cognitive-Behavioral Therapy
- Group 4: Exercise Training Only
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger